Immutep (IMMP) Depreciation & Amortization (CF) (2019 - 2024)
Immutep (IMMP) posted Depreciation & Amortization (CF) of $1.5 million for Q2 2024, up 8.17% on a QoQ basis from $1.4 million in Q2 2023, and up 8.17% year-over-year from $1.4 million in Q3 2023.
Immutep (IMMP) Depreciation & Amortization (CF) (2019 - 2024) Analysis & Trends
Immutep's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $1.5 million for Q2 2024.
- Quarterly Depreciation & Amortization (CF) rose 8.17% year-over-year to $1.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 48.04% YoY) and the FY2024 annual result came in at $1.5 million, up 8.17% from the prior year.
- Depreciation & Amortization (CF) was $1.5 million for Q2 2024 at Immutep, up from $1.4 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.5 million in Q2 2024 and bottomed at $1.4 million in Q2 2020.
- A 3-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) increased 3.55% — and 2024, when it rose 8.17%.
- Immutep's Depreciation & Amortization (CF) stood at $1.4 million in 2020, then grew by 1.1% to $1.4 million in 2023, then gained by 8.17% to $1.5 million in 2024.
- Business Quant data shows IMMP's Depreciation & Amortization (CF) at $1.5 million in Q2 2024, $1.4 million in Q2 2023, and $1.4 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Jun 30, 2019 | 1.32 Mn |